MedTrace Logo

Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome

NCT00542295 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2008-10-01

No results posted yet for this study

Summary

To assess the effectiveness of alverine citrate and simeticone on IBS symptoms according to the latest recommended design

Conditions

  • Irritable Bowel Syndrome

Interventions

DRUG

alverine citrate and simeticone

DRUG

placebo

Sponsors & Collaborators

  • Laboratoires Mayoly Spindler

    lead INDUSTRY

Principal Investigators

  • Philippe Ducrotte, M.D

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-07-31
Completion
2008-09-30

Countries

  • Hungary
  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00542295 on ClinicalTrials.gov